SynthesisThe Indian journal of medical research2026
Microalbuminuria in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Synthesis in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives We conducted this systematic review and meta-analysis to determine the prevalence of microalbuminuria in patients with chronic obstructive pulmonary disease (COPD) and its association with COPD severity. Methods We conducted a literature search in PubMed, Embase, Scopus, Web of Science, Cochrane Library, and the Virtual Health Library from inception to December 31th, 2024. The search strategy was: ('chronic obstructive pulmonary disease' OR COPD OR 'chronic airflow obstruction' OR emphysema OR 'chronic bronchitis') AND (microalbuminuria OR albuminuria OR proteinuria OR 'urinary albumin creatinine ratio' OR 'urinary albumin excretion'). We included studies recruiting patients diagnosed by spirometry and providing data of microalbuminuria prevalence. We excluded studies in patients with other respiratory diseases associated with COPD, and studies published in predatory journals. The pooled prevalence of microalbuminuria was calculated using the DerSimonian-Laird binary random effects method, and the association of microalbuminuria with COPD and its severity was assessed using the Mantel-Haenszel random effects method. Results Twenty-five articles were included. The prevalence of microalbuminuria in patients with COPD was 49.3% [95% confidence interval (CI) 34.3-64.4%], which was higher than in the control population, with an estimated odds ratio of 3.94 (95% CI 2.25-6.60). In patients with severe to very severe COPD, it was higher than in those with mild to moderate COPD, with an estimated odds ratio of 4.55 (95%IC 2.85-7.28). Patients with COPD and microalbuminuria had an estimated decrease in PaO2 of 9.98 mmHg (95% CI 13.94-6.02) and an increase in PaCO2 of 8.08 mmHg (95% CI: 4.87-11.29). Interpretations and conclusions Microalbuminuria is highly prevalent in patients with COPD, with a much higher frequency than in the general population. It is more common in patients with more severe airflow obstruction and is associated with hypoxia and hypercapnia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.